Cases & Deals

Athersys completes registered direct offering of Common Stock

Clients Athersys, Inc.

Jones Day advised Athersys, Inc., a clinical stage biopharmaceutical company, in connection with its sale of 4,366,667 shares of Common Stock and Warrants to purchase an additional 1,310,000 shares of Common Stock in a registered direct offering.